For the first time, WHO’s treatment tips include a transparent advice for the use of extended-acting injectable cabotegravir and rilpivirine (CAB/RPV) instead switching option for antiretroviral therapy (Artwork) for Grownups and adolescents who've realized full viral suppression on oral ART and don't have Lively hepatitis B an infection. These illustrations https://maps.app.goo.gl/SucmaxKzrENyUBfj9